Calling practically minded, hands-on designers. Come and join our team to manage the small workshop and design our new products.
Puridify was successful leading this application for a £2,354,840 Industrial Research project from Innovate UK’s Industrial Biotechnology Catalyst program. This will see Puridify and University College London carry out the industrial validation of the nanofibre platform technology for biotherapeutic manufacture driving forward the technology’s commercialisation. This work is co-funded by the Engineering and Physical Sciences Research Council (EPSRC) and the Biotechnology and Biological Sciences Research Council (BBSRC).
Looking for a new opportunity to become part of a rapidly growing company and be integral to the shaping of a new technology for industrial bioprocessing?
Do you have 3+ years experience working in process development with a focus on chromatographic purification in a globally recognised CMO, Pharma/biopharma or an equipment supplier?
Iwan Roberts, COO, presents at this KTN event and discusses “Process development strategies for the manufacture of challenging proteins”
Iwan Roberts, COO, presents at the ESCAT-UK’s 2015 Annual Scientific Meeting and discusses the rapid evolution in downstream processing
Imperial Innovations Group plc (AIM:IVO, ‘Innovations’), the leading technology commercialisation and investment company and S.R.One Ltd, GlaxoSmithKline’s venture capital fund, announce today that they have led, alongside co-investor UCL Business PLC (UCLB), an £850,000 seed financing for Puridify, a newly formed company providing purification solutions for biotherapeutic manufacturing.
Puridify was successful leading this application for a £499,728 Technology-inspired innovation – Biosciences project from the Technology Strategy Board’s Collaborative R&D award program. This will see Puridify and University College London develop and test its platform technology with a series of scale down prototypes with key end users driving forward the technology’s commercialisation. This work is co-funded by the Biotechnology and Biological Sciences Research Council.